Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-25-005986
Filing Date
2025-04-30
Accepted
2025-04-30 16:01:37
Documents
105
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K scpx-20241231x10k.htm   iXBRL 10-K 3116631
2 EX-4.14 scpx-20241231xex4d14.htm EX-4.14 31018
3 EX-19.1 scpx-20241231xex19d1.htm EX-19.1 47824
4 EX-23.1 scpx-20241231xex23d1.htm EX-23.1 3710
5 EX-31.1 scpx-20241231xex31d1.htm EX-31.1 35200
6 EX-31.2 scpx-20241231xex31d2.htm EX-31.2 33432
7 EX-32.1 scpx-20241231xex32d1.htm EX-32.1 15879
8 EX-32.2 scpx-20241231xex32d2.htm EX-32.2 17497
  Complete submission text file 0001558370-25-005986.txt   14346500

Data Files

Seq Description Document Type Size
9 EX-101.SCH scpx-20241231.xsd EX-101.SCH 108846
10 EX-101.CAL scpx-20241231_cal.xml EX-101.CAL 124744
11 EX-101.DEF scpx-20241231_def.xml EX-101.DEF 437576
12 EX-101.LAB scpx-20241231_lab.xml EX-101.LAB 953049
13 EX-101.PRE scpx-20241231_pre.xml EX-101.PRE 717332
108 EXTRACTED XBRL INSTANCE DOCUMENT scpx-20241231x10k_htm.xml XML 2365114
Mailing Address 1305 E. HOUSTON STREET BUILDING 2 SAN ANTONIO TX 78205
Business Address 1305 E. HOUSTON STREET BUILDING 2 SAN ANTONIO TX 78205 919-240-7133
Scorpius Holdings, Inc. (Filer) CIK: 0001476963 (see all company filings)

EIN.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35994 | Film No.: 25894769
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)